🧾 What This Document Is

This is Bruker Corporation's official 2026 Proxy Statement, also known as a "DEF 14A." Think of it as a detailed invitation and guidebook for the company's upcoming Annual Meeting of Shareholders.

👉 In simple terms: The Board of Directors is giving shareholders the information they need to vote on key company decisions. This includes who should sit on the Board, how much top executives should be paid, and which accounting firm should check the company's books.

The meeting will be held virtually on Thursday, May 21, 2026, at 10:00 a.m. Eastern Time. Shareholders as of the record date (April 1, 2026) get to vote.

🏢 What The Company Does

Bruker Corporation is a global leader in high-performance scientific instruments. Imagine the advanced tools used in research labs to analyze materials, discover new drugs, or study biological samples—that's Bruker's territory.

👉 In simple terms: They make and sell complex machines like mass spectrometers, nuclear magnetic resonance (NMR) spectrometers, and electron microscopes. Their customers are scientists in pharmaceutical companies, universities, government labs, and industrial firms. It's a business driven by innovation and precision.

🗳️ What Shareholders Are Voting On

The meeting has three main items for shareholders to decide:

1. Proposal 1 - Elect Directors: Vote to approve 12 nominees to the Board, including the founder-CEO.
2. Proposal 2 - Approve Executive Pay: A non-binding "Say-on-Pay" vote to approve the 2025 compensation for top executives.
3. Proposal 3 - Ratify the Auditor: Confirm the selection of PricewaterhouseCoopers LLP as the independent accounting firm for 2026.

👉 Why it matters: These votes are your main tool as a shareholder to influence the company's leadership and governance.

👥 The People in Charge

Board Nominees & Leadership: The Board has a classified structure (directors serve 3-year terms) and a combined Chairman/CEO role.

• Frank H. Laukien, Ph.D. (Age 66) is the Chairman, President, and CEO. He founded the company, has led it since 1991, and is its largest shareholder (26.6% stake). The Board believes his deep alignment with shareholders makes the combined role appropriate.
• Richard A. Packer (Age 68) is the Lead Independent Director, appointed to provide strong independent oversight.

The nominees include experts in diagnostics, finance, medical devices, and life sciences tools. The full list and their biographies are in the document to show their relevant experience.

💰 Executive Compensation (The "Say-on-Pay" Vote)

This is a major focus. Bruker's philosophy is "pay-for-performance"—a significant portion of executive pay should be "at-risk" and tied to company success.

2025 Financial Performance (The "Scorecard"):

• Revenue: $3.437 billion (Up 2.1%, but organic revenue was down 3.7%)
• Non-GAAP Operating Margin: 12.6% (Down 2.8 percentage points)
• Non-GAAP Diluted EPS: $1.83 (Down 24.1% from $2.41 in 2024)
  • Why it matters: These numbers are the backdrop for executive pay decisions. Performance was mixed, with growth from acquisitions but pressure on margins and earnings.

How Pay is Structured:

1. Base Salary: Fixed annual pay.
2. Annual Cash Bonus: Tied to company financial goals (like revenue growth, operating profit) and individual objectives.
3. Long-Term Incentives (LTI): Primarily stock options and restricted stock units (RSUs) that vest over time, to align executives with long-term shareholder interests.

The Pay Packages (2025): The document details every dollar. For example:

• CEO Frank Laukien's Total 2025 Compensation: $10,296,347 (This includes his base salary, a bonus of $1.9M, and over $7.8M in stock awards).
• The company uses a peer group of 15 similar-sized science and tech companies (like Agilent, Waters, and Mettler Toledo) to benchmark competitive pay.

👉 Why it matters: This vote asks you if you agree that the pay is fair and appropriately linked to performance, especially given the mixed 2025 results.

⚖️ Governance & Oversight

Committees & Risk Management: The Board delegates key work to specialized committees:

• Audit Committee: Oversees financial reporting, audits, and cybersecurity risk. It has an "audit committee financial expert" as its chair.
• Compensation Committee: Designs the executive pay program to avoid encouraging excessive risk-taking.
• Nominating & Governance Committee: Recruits directors and oversees governance policies.

Corporate Social Responsibility (ESG): Bruker highlights its commitments in three areas:

1. Environmental: Tracking emissions, using renewables, managing waste.
2. Social: Employee safety, training, community engagement.
3. Governance: A strong Code of Conduct and anti-corruption policies.

🔮 What's Next & Broader Context

• For 2026: Shareholders will vote on the proposals, and the company will continue executing its strategy of innovation and acquisition-driven growth.
• The Bigger Picture: Bruker is navigating a challenging environment with softer demand from academic and government customers. The compensation plan is designed to incentivize executives to improve margins and earnings despite these headwinds. The strong insider ownership of the CEO is a key factor in the Board's governance decisions.

⚖️ Strengths & Risks

• 👍 Strengths:
  • Strong Founder Leadership: CEO has deep alignment as largest shareholder.
  • Focused Niche: Leader in high-margin, essential scientific tools.
  • Structured Governance: Clear committee oversight for audit, pay, and governance.
• ⚠️ Risks:
  • Market Sensitivity: Performance is tied to academic/government funding cycles.
  • Integration Risk: Growth relies on successfully integrating acquisitions.
  • Complex Pay: The intricate compensation structures can be difficult for shareholders to fully evaluate.

🧠 The Analogy

Think of Bruker's Board as the crew of a sophisticated research vessel. The CEO (Captain Laukien) owns a significant part of the ship and has steered it for decades. The other directors (the crew) are experts in navigation, engineering, and logistics. This proxy statement is the ship's log and mission plan presented to the owners (shareholders). You are being asked to confirm the crew's leadership, approve their rewards for the last voyage (2025), and authorize the port authority (PwC) to inspect the ship's books before the next expedition.

🧩 Final Takeaway

This proxy is your annual check-in on Bruker's leadership. The key asks are to re-approve the experienced director slate (which includes the founder/CEO), endorse a "pay-for-performance" executive compensation plan that navigated a mixed 2025, and retain the company's auditor. Your vote signals your confidence in the current strategy and stewardship.